Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+Gm+REOm+EDS, avian infectious bronchitis,Newcastle disease,avian infectious bursal disease,avian reovirus,egg drop syndrome virus vaccine (inactivated), Status: Authori

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+Gm+REOm+EDS, avian infectious bronchitis,Newcastle disease,avian infectious bursal disease,avian reovirus,egg drop syndrome virus vaccine (inactivated), Status: Authorised

Human medicines European public assessment report (EPAR): Latuda, lurasidone, Date of authorisation: 21/03/2014, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Latuda, lurasidone, Date of authorisation: 21/03/2014, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Circadin, melatonin, Date of authorisation: 29/06/2007, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Circadin, melatonin, Date of authorisation: 29/06/2007, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 23, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 July 2025 to 10 July 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 July 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 July 2025 to 10 July 2025

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness